AdventHealth Research Institute Researchers to Present at American Diabetes Association Scientific Sessions

AdventHealth Research Institute (AHRI) is proud to have a strong presence at the American Diabetes Association (ADA) 2026 Scientific Sessions, with multiple investigators and research team members attending and contributing to leading discussions in diabetes research.

As one of the premier global forums for advancing diabetes science, the ADA Scientific Sessions bring together researchers, clinicians and thought leaders committed to improving outcomes for patients and advancing the future of care.

Featured Presentations

Several AHRI investigators have been selected to present their work, highlighting the institute’s continued contribution to advancing understanding of metabolic health and type 1 diabetes.

• Karen Corbin, PhD, RD, FTOS will present:

“Targeted Microbiome Modification: Not Quite Ready for Clinical Practice” as part of the session: HOPE OR HYPE? Microbiome as New Frontier for Type 2 Diabetes and Obesity on

Friday, June 5, 2026, | 1:00-1:15 PM

• Anika Bilal, MD will deliver two oral presentations:
  “Extracellular Vesicle (EV) Proteomics Distinguishes Partial Clinical Remission (PCR) in New-Onset Type 1 Diabetes (T1D)” as part of session “Beyond A1C: New Ways to Measure Disease Progression in Early-Stage Type 1 Diabetes?” Friday, June 5, 2026, | 1:00-1:15 PM

“Hybrid Closed-Loop Increases Time in Tight Range while Reducing Hypoglycemia in Older Adults with Type 1 Diabetes: Pooled Analysis from Three Randomized Controlled Trials” as part of the session “Hypoglycemia across Contexts: Risk, Recognition, and Real-World Safety” Friday, June 5, 2026, | 3:00-3:15 PM

• Daria Igudesman, PhD, RD will present:
  “Impaired Metabolic Flexibility in Type 1 Diabetes May Be Offset by Greater Physical Activity” as part of the session: “Metabolic Flexibility in Humans: Integrating Organ Fuel and Metabolite Handling (With ADA Presidents’ Select Abstract Presentation)” on Saturday, June 6, 2026, | 1:30-1:45 PM
• Paul Coen, PhD will present one oral and one poster presentation:

“New Molecular Insights on How Exercise Impacts Skeletal Muscle Metabolism: Findings from the Molecular Transducers of Physical Activity Consortium (MoTrPAC)” as part of the Professional Interest Group: Discussion on Exercise Physiology on June 6, 2026, | 11:55pm-12:15 PM

Physical Inactivity Induced by Bed Rest Reduces Muscle but Not Hepatic or Adipose Tissue Insulin Sensitivity in Older Adults with or without Pre- or Type 2 Diabetes on Sunday, June 7, 2026 | 12:30-1:30 PM

• Christian Elliehausen, PhD will present two posters during the Poster Session:

“From Mouse to Human: Translational Insights into Metabolism” on Saturday, June 6, 2026, | 12:30-1:30 PM

“Older Adults with Prediabetes or Type 2 Diabetes Experience Poor Recovery of Muscle Power and Torque but Not Volume following 10 Days of Bed Rest” on Sunday, June 7, 2026 | 12:30-1:30 PM

AHRI Representation at ADA 2026

AHRI researchers and leaders attending include:

• Anna Casu, MD, Associate Investigator
• Paul Coen, PhD, Associate Investigator
• Karen Corbin, PhD, RD, FTOS, Associate Investigator
• Kaitlin Love, MD, Associate Investigator
• Richard Pratley, MD, Senior Investigator
• Tina Thethi, MD, MPH, Associate Investigator
• Yury Nunez Lopez, PhD, Research Scientist
• Anika Bilal, MD, Postdoctoral Fellow
• Christian Ellienhausen, PhD, Postdoctoral Fellow
• Daria Igudesman, PhD, RD, Postdoctoral Fellow
• Emeline Masterson, PhD, Postdoctoral Fellow

Advancing Discovery, Improving Lives

"The Scientific Program Committee of the ADA recently selected 3 abstracts submitted by researchers from the AdventHealth Translational Research Institute Diabetes Program for their Presidential Select Abstract Designation. These prestigious awards reflect the strength of AdventHealth’s scientific community and our commitment to advancing meaningful discoveries in diabetes,” said Dr. Richard Pratley, Samuel E. Crockett Chair in Diabetes Research, Medical Director of the AdventHealth Diabetes Institute, and Senior Investigator and Diabetes Program Lead at the AdventHealth Translational Research Institute. “By sharing these findings with the broader scientific community, we are helping advance understanding and accelerate progress toward more effective approaches to prevention, treatment and care.

“These presentations highlight the strength of our research ecosystem and the collaboration required to bring meaningful discoveries forward,” said Rob Herzog, Vice President of Research. “We are proud of our teams for advancing work that not only contributes to the scientific community but ultimately brings hope to the patients and families we serve.”

Rooted in AdventHealth’s commitment to whole-person care, this work reflects a broader mission to care for the body, mind and spirit -- advancing research that supports healthier futures for individuals living with diabetes.